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Abstract
Adenylyl cyclases of the type II family differ from other subforms in that they are conditionally stimulated via a rbgs
subunits and regulated by PKC mediated phosphorylation. AC II, stably expressed in HEK 239 cells, was incubated with the
 . w32 xPKC activator tetradecanoylphorbol acetate TPA . Using cells metabolically labeled with P phosphate, TPA caused
w32 xconcerted stimulation of basal and forskolin activated adenylyl cyclase together with incorporation of P phosphate into
AC II protein. Enhanced phosphorylation was also indicated by a monoclonal anti-phosphothreonine antibody. Assignment
w32 xof TPA-induced P phosphate-incorporation to specific sites was achieved by a combination of chemical and immuno-
w32 xchemical methods. Three out of five P labeled peptides that were generated by fragmentation with N-chlorosuccinimide
w  . xwere also recognized by the monoclonal antibody BBC-4 S. Mollner, T. Pfeuffer, Eur. J. Biochem. 171 1988 265–271
directed against an epitope 8 kDa from the extreme C-terminus. These findings suggested Ser-871 consensus sequence
.  .ARSLK and Thr-1057 CTCR as acceptor candidates of phorbolester induced phosphoryl transfer. q 1997 Elsevier
Science B.V.
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1. Introduction
To date eight mammalian isoforms of adenylyl
cyclase have been characterized that differ in the way
in which they are regulated. Three of them, types I,
III and VIII, appear to be stimulated by
Ca2qrcalmodulin but only one of these, AC I, is
Abbreviations: TPA, tetradecanoyl phorbolacetate; H89, N-
w  .x2- p-bromocinnamyl-amino-ethyl -5-isoquinoline sulfonamide
=2 HCl; TPCK, N-tosyl-L-phenylalanine chloromethylketone;
TLCK, N-tosyl-L-lysine chloromethylketone; HEK, human em-
 .bryonic kidney; HEK 293 AC II , HEK 293 cells stably express-
ing adenylyl cyclase II
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inhibited by the bg-subunit of trimeric G-proteins.
AC V and AC VI are the most closely related
isoforms, both are inhibited by submicromolar con-
centrations of Ca2q and both are insensitive to regu-
lation by bg-subunits. Adenylyl cyclases types II and
IV likewise exhibit high sequence homology, thus
displaying similar biochemical properties: insensitiv-
ity to Ca2q regulation and stimulation via G beingsa
w xconditionally enhanced by bg-subunits 1 .
In contrast to the regulation of adenylyl cyclase
activity via protein–protein interaction, regulation by
posttranslational modification is largely unknown.
Recently we could provide evidence that adenylyl
cyclases from myocardial membranes and human
thrombocytes are stimulated by fatty acylation, since
0167-4889r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
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treatment by neutral hydroxylamine caused concomi-
tant deacylation and a decrease in enzymatic activity
w x2 . Yet information is lacking whether acylation is
hormonally influenced.
Regulation by phosphorylation seems to be of
particular interest since it offers a possibility for
cross-talk with other signalling pathways but also for
the regulation of cAMP formation by feedback inhi-
bition via PKA. Recent studies have indicated that
several adenylyl cyclase subtypes may be stimulated
via PKC mediated phosphorylation, usually accom-
plished by treatment of whole cells with the phor-
bolester TPA. Stimulation by TPA could be observed
with adenylyl cyclase subtypes I, II, III, V and VI,
w xexpressed in various tissue culture cells 3–6 . On the
other hand purified adenylyl cyclase V could be
directly stimulated by PKC a and PKC z . Enhance-
ment of adenylyl cyclase V activity was paralleled by
w32 xincorporation of P ortho-phosphate into cyclase
w xprotein 7 . However the site of phosphorylation re-
mains elusive, which also holds true for the respec-
w32 xtive site in P labeled AC II expressed in Sf-9-cells
w x8 .
In order to answer the question of localisation, we
have used AC II stably expressed in HEK 293 cells.
w32 xFollowing TPA stimulation of P phosphate-meta-
bolically labeled cells, cyclase was purified by im-
w32 xmunoprecipitation. The site of P phosphorylation
was then approached by site specific cleavage and
immunospecific detection of fragments in SDS gels.
2. Materials and methods
2.1. Materials
N-Chlorosuccinimide and N-acetylmethionine
were obtained from Sigma; PNGase F N-glycosidase
.F, EC 3.5.1.2 , creatine phosphate, creatine kinase,
 .alkaline phosphatase molecular biology grade were
from Boehringer Mannheim; anti-phosphothreonine
 .antibody 1E11 and H89 were from Biomol; Pan-
sorbin cells were from Calbiochem and CSPD was
purchased from Serva. The ECL system was the
product of Amersham. Immobilon P transfer mem-
w 32 xbranes were obtained from Millipore. a P ATP
 . w3 x  .760 Cirmmol and H cAMP 15–30 Cirmmol
w32 xwere purchased from Amersham. P orthophos-
 .phate carrier free was from ICN; Kodak Biomax
MS-Film was used for autoradiography.
2.2. Miscellaneous
Polyacrylamide gel electrophoresis according to
w xLaemmli 9 and immunoblotting were conducted as
w xdescribed previously 10,11 . Monoclonal antibody
BBC-4, labeled with alkaline phosphatase, was used
for detection by chemiluminescence with CSPD as
substrate. Phosphatase was coupled to antibody ac-
cording to the specifications of the distributor.
Adenylyl cyclase assays were performed in the pres-
ence of 5 mM MgCl and 100 mM forskolin as2
w xdescribed earlier 12 .
2.3. Membrane preparation
Cells were lysed by freezerthaw in 10 mM Tris
buffer, pH 7.4, 1 mM EDTA, 0.5 mM DTT, 0.5 mM
PMSF, 3.2 mgrml TPCK, 22 mgrml TLCK, 3.2
mgrml soybean trypsin inhibitor, 2.8 mgrml Trasy-
lol, 1 mM benzamidine, 0.1 mM benzethonium chlo-
ride, 10 mM NaF and 1 mM Na VO . Membranes3 4
were prepared by differential centrifugation and stored
in the above buffer supplemented with 10% glycerol
at y808C.
2.4. Stable transfection of HEK 293 cells
HEK 293 cells were grown at 378C in minimum
 .essential medium MEM supplemented with 10%
fetal bovine serum in a humidified 95% airr5% CO2
incubator. The full length cDNA for rat type II
w xadenylyl cyclase 13 was excised from pBluescript
w xwith EcoRI, introduced into pXM D1 14 and, to-
gether with pRSV neo, used for transfection of HEK
293 cells by the calcium phosphate method.
Neomycin-resistant cells were selected in culture
 .medium containing G 418 400 mgrml .
[ 32 ]2.5. Stimulation of P phosphate labeled cells with
TPA
2=108 cells were starved for 2 h at 378C in MEM
without phosphate, supplemented with 10% dialysed
FCS, at a cell density of 1=107rml. 0.25 mCirml
w32 xP ortho-phosphate was added for another 2 h.
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Stimulation was carried out during the last 15 min of
incubation by addition of 1 mM TPA in DMSO
which also served as control.
2.6. Immunoprecipitation with monoclonal antibody
BBC-4
The generation of the latter has been described
w xpreviously 10,11 . It recognizes a conserved epitope
since it is competed by a synthetic peptide from AC
.I corresponding to a sequence 1003 G–1023 T of
AC II. For immunoprecipitation, monoclonal anti-
body BBC-4 was coupled to Pansorbin as described
w xearlier 12 . Prior to precipitation, solutions, contain-
ing SDS-solubilized membranes, were adjusted to
RIPA buffer conditions and treated with unconju-
gated pansorbin for preclearing. The supernatant was
mixed with the BBC-4rPansorbin complex 400 ml
.of a 10% slurry per mg membrane protein . The
slurry was agitated overnight at 48C. Following cen-
trifugation, the pellet was washed twice with RIPA
buffer, once with buffer A 10 mM MOPS, 1 mM
MgCl , 100 mM NaCl, 1 mM EDTA, 1 mM Tween2
.  .60, pH 7.4 , suspended in buffer A 50% slurry and
finally stored at y208C. For fragmentation experi-
ments, adenylyl cyclase was eluted from the BBC-
4rPansorbin complex with 0.5% SDS at 508C for 10
min and separated from the pansorbin by centrifuga-
tion.
( )2.7. Clea˝age with N-chlorosuccinimide NCS
This was performed essentially according to Lis-
w x w32 xchwe and Ochs 15 . P phosphorylated adenylyl
cyclase released from the antibody–Pansorbin com-
plex as described above, was separated by SDS-poly-
 .acrylamide gel electrophoresis 5–15% . AC II was
localized by autoradiography, excised from gel pieces
and electroeluted using a Schleicher and Schuell
‘Biotrap’ device. Eluted protein was concentrated by
 .Centricon Amicon centrifugation and treated with
2.5 volumes of cleavage solution 7 M urea in 30%
.acetic acid including 10 mM of NCS for 30 min at
228C. The reaction was stopped by addition of an
equimolar amount of N-acetylmethionine. The mix-
ture was centrifuged through Sephadex G 25, previ-
ously equilibrated with 1 mgrml BSA in buffer A,
dried down in a Speed Vac and separated by SDS-
 .polyacrylamide gel electrophoresis 5–20% gradient .
3. Results
AC II, stably expressed in HEK 293 cells resulted
in highly elevated adenylyl cyclase activity 6 nmol
y1 y1.=mg =min in the presence of forskolin. On
Western blot analysis using a monoclonal antibody
 . w xBBC-4 , recognizing a conserved epitope 16 , a
doublet at M s 125 and 145 kDa appeared. Theser
bands, absent in nontransfected cells, were of vari-
able relative intensity. However treatment of mem-
branes with PNGase F shifted the pattern towards the
lower M band, indicative for partial deglycosylationr
of the 145 kDa species low M -bands at about 60r
and 30 kDa are most likely degradation products
.  .normally absent as in Fig. 5B Fig. 1 .
Fig. 2 shows that membranes from HEK 293 AC
.II cells which have been treated with TPA, exhibit
an enhancement in basal and forskolin stimulated
activity. Saturation was observed at 1 mM of the
Fig. 1. Heterogeneity of expressed AC II is due to glycosylation.
 .  .HEK 293 AC II membranes 75 mg in 5 mM EDTA, 6%
NP-40, 0.5% SDS, 0.5% b-mercaptoethanol, 1 mM phenyl-
methylsulfonylfluoride, 100 mM sodium phosphate buffer, pH
7.2 were incubated in the presence and absence of 1 U PNGase F
for 17 h at 378C. The mixture was solubilized in Laemmli buffer
w x9 , separated by SDS polyacrylamide electrophoresis, blotted
onto immobilon membrane and visualized with BBC-4–alkaline
phosphatase and chemiluminescence as described in Section 2.
Arrowheads refer to the 125 and 145 kDa forms of AC II.
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 .  .Fig. 2. TPA induced stimulation of membrane bound AC II. A HEK 293 AC II cells were incubated for 15 min at 378C in the
presence of the indicated concentrations of TPA. Cells were lysed and membranes prepared. Adenylyl cyclase activity was measured in
 .  .membranes in the presence or absence basal of forskolin 100 mM for 20 min at 308C, as described in Section 2. The data represent the
mean"SD of at least triplicate experiments.
phorbolester, in agreement with the results from simi-
lar studies with different cell types.
The extent of stimulation by TPA proved to be
variable, especially when measured in the absence of
forskolin. We therefore argued, whether some non-
phorbolester stimulated protein kinase might be re-
sponsible for the elevated background. Out of a series
of different kinase inhibitors, H89 most favourably
allowed to improve the extent of stimulation by TPA.
Fig. 3A shows, that inclusion of H89 reduced the
adenylyl cyclase activity preferably in the absence of
TPA, and thus enhanced the fold-stimulation by the
latter from 1.4 and 1.5 to 2.2 and 2.7 for basal and
forskolin stimulated activities. The action of H89 was
w32 xalso reflected by the incorporation of P into
 .adenylyl cyclase: HEK 293 AC II cells were
w32 xmetabolically labeled with P phosphate, treated
with H89 and finally stimulated for 15 min with or
without TPA. Phosphorylated adenylyl cyclase was
then precipitated with the monoclonal antibody BBC-
 .4 Fig. 3B . In a typical experiment the ratio of
"TPA of 1.6 in non-treated cells rose to a ratio of
2.8 in H89-treated cells following quantitation by a
Phospho-Imager device.
In order to find out whether TPA-stimulated phos-
phorylation of adenylyl cyclase occurred at serine or
threonine residues or both we applied two recently
available monoclonal antibodies against phospho-
serine and phosphothreonine. While no conclusive
result could be obtained with the anti-phosphoserine-
antibody, TPA sensitive incorporation of phosphate
into AC II could be shown with the anti-phospho-
 .threonine antibody Fig. 4 .
The data depicted in Figs. 3 and 4 clearly demon-
strate that adenylyl cyclase type II was specifically
phosphorylated when cells were stimulated with the
phorbolester TPA. The consistent stoichiometry of
1.6"0.2 mol phosphate per mol adenylyl cyclase
could be found in three independent experiments.
For determination of the site of phosphorylation
within AC II we took advantage of a technique which
we have recently successfully applied for the localisa-
w xtion of the ATP-site in type I adenylyl cyclase 16 .
In order to prevent trace contaminations, immunopre-
w32 xcipitated P labeled adenylyl cyclase was further
purified by preparative polyacrylamide gel elec-
trophoresis. Fragmentation was then performed by
treatment with N-chlorosuccinimide, an agent which
selectively cleaves at tryptophan residues. Since frag-
ments were identical irrespective of deglycosylation
the latter procedure had been omitted.
w32 xThe results in Fig. 5 show the P phosphorylated
fragments in an autoradiograph. In parallel, fragments
were also probed by Western blot analysis via chemi-
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Fig. 3. The protein kinase inhibitor H89 modulates the effects of
 . w32 xTPA on adenylyl cyclase activity A and P -incorporation
 .  .  .B . A HEK 293 AC II cells were incubated for 2 h at 378C
 .with and without H89 5 mM and then treated with and without
1 mM TPA for further 15 min. Adenylyl cyclase activity was
 .  .measured with and without basal forskolin 100 mM as de-
scribed in Section 2. Numbers on top of bars refer to fold
 .  .stimulation. B HEK 293 AC II cells were equilibrated with
w32 x  .P phosphate and then treated with H89 and TPA as in A .
Adenylyl cyclase was immunoprecipitated with BBC-4 antibody,
electrophoresed and immunoblotted. Shown is an autoradiograph.
The data are the mean"SD of experiments done at least in
triplicate.
luminescence using the monoclonal antibody BBC-4.
From the autoradiograph in Fig. 5A it is obvious that
w32 xout of five P labeled bands of M s 5, 8, 21, 25 andr
29 kDa those of M s 8, 21 and 29 were significantlyr
more intensive when the sample was derived from
TPA-treated cells. Fig. 5B shows that the higher Mr
bands at 21, 25 and 29 kDa were also detected by
immunoblotting and chemiluminescence analysis, but
expectedly did not exhibit any difference in intensity
between samples from control and TPA treated cells,
confirming that equal amounts of membrane protein
have been used.
Fig. 6 shows the theoretical fragmentation pattern
by NCS of adenylyl cyclase type II. The sizes of
fragments are given in context with the putative PKC
consensus phosphorylation sites. The BBC-4 epitope
is situated near the C-terminus of the 21 kDa frag-
 .ment see Section 2 . Thus, in addition to the latter
the antibody also recognized a 21q8 kDa fragment,
Fig. 4. Detection of phosphorylated type II adenylyl cyclase by
an anti-phospho-threonine antibody. Phosphorylated adenylyl cy-
clase II from cells sequentially treated with and without TPA,
immunoprecipitated with BBC-4, blotted onto immobilon P
membrane as in legend to Fig. 1 was also visualized with a
 .monoclonal anti-phosphothreonine antibody 1E 11, Biomol fol-
lowed by a second anti-mouse-IgG-antibody coupled to peroxi-
 .dase. Bound antibody was probed with ECL Amersham . Ar-
rowheads point to the 125 and 145 kDa species of AC II. The
band at 30 kDa is due to nonspecific reaction of the second
antibody.
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Fig. 5. Chemical fragmentation of phospho-adenylyl cyclase II at
 .tryptophan residues. Adenylyl cyclase from HEK 293 ACII
w32 xcells, equilibrated with P phosphate and stimulated with and
without 1mM TPA was immunoprecipitated and electrophoresed
as outlined in legend to Fig. 3. Following further purification by
w32 xpreparative SDS gel electrophoesis P labeled AC II was treated
with NCS as described in Section 2. Following electrophoretic
 .separation 5–20% SDS-gel , proteins were blotted onto immo-
 .bilon P membrane and either autoradiographed A or visualized
 .by chemiluminescence B as described in Section 2.
w32 xwhich had elevated P phosphate incorporated when
stimulation occurred with TPA. In contrast, the 8 kDa
fragment, as predicted, was not recognized by the
antibody. However, the 25 kDa fragment, also de-
tected by the antibody was not significantly differ-
w32 xently labeled with P .
The data are essentially consistent with the pres-
ence of two PKC phosphorylation sites within the
amino acid sequence of AC II: one serine-containing
sequence in the penultimate 21 kDa fragment Ser-
.871 and one threonine-containing sequence on the
 .very last C-terminal fragment Thr-1057 .
4. Discussion
Almost any of the adenylyl cyclase subtypes has
been shown to be affected by phorbolester stimulated
putative phosphorylation via PKC. But only in adeny-
lyl cyclase type II the simultaneous action of PKC
mediated phosphorylation together with the condi-
tional stimulation of a -mediated hormone actionss
appear to be physiologically meaningful. Both effects
are triggered by Ca2q-mobilizing hormones via bg-
w xsubunits of G - or G -species 1,17 . Therefore thei q
site of phosphoryl transfer via phorbolester stimu-
lated PKC on adenylyl cyclase II appears to be of
elevated interest. A recent approach making use of
 .chimeras between AC I nonresponsive to PKC and
 .AC II responsive to PKC , identified a small, well
defined region near the C-terminus of AC II, neces-
sary for activation by PKC. Unfortunately, this region
lacked serine or threonine residues as part of a PKC
w xphosphorylation consensus sequence 18 .
Treatment of stably expressed AC II in HEK 293
cells with TPA clearly elevated enzymatic activity
and enhanced phosphorylation of adenylyl cyclase.
The effect on both could be greatly improved by
incubation with the kinase inhibitor H89. The effect
of the latter deserves a comment. It is known as a
kinase inhibitor with a certain degree of selectivity
for PKA. PKA has been shown to serve as a feedback
inhibitor of adenylyl cyclase although this has been
w xonly demonstrated for AC V 19 . In the present case
however the opposite effect should have occurred,
namely enhancement of adenylyl cyclase activity in
the presence of the inhibitor. Thus, the effect of H 89
remains to be clarified.
The previously applied method of chemical frag-
mentation combined with the use of site-specific
Fig. 6. Theoretical fragmentation pattern by NCS of adenylyl cyclase type II including PKC-consensus phosphorylation sites. Vertical
lines refer to tryptophan residues. Numbers indicate size of fragments in kDa. Thick arrow marks the epitope recognized by antibody
BBC-4. Thin arrows indicate Ser 871 and Thr 1057, respectively, as suggested phosphate acceptors following TPA treatment.
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w xmonoclonal antibodies 16 was also successfully ex-
ploited here for the localisation of the putative PKC-
mediated phosphorylation sites within the AC II se-
quence. The list of at least five PKC consensus
sequences could be narrowed down to two potential
sites comprising amino acids serine-871 and threo-
nine-1057.
This finding represents the starting-point for forth-
coming experiments involving site-directed mutagen-
esis in order to decide whether only one or both
phospho-acceptors are involved in PKC-mediated
regulation. Further studies are also on the way to see
whether different isoforms of PKC may have differ-
ent target sites on the AC II molecule.
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